AzTrials
AzTrials

CABGCABGNCT07039812

The Effect of Virtual Reality and Eye Mask During Dressing After CABG Surgery

A study testing Virtual Reality Headset and Eye Mask in people with CABG and Physiological Parameter, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effects of virtual reality (VR) and eye mask (EM) applications on pain, anxiety, and physiological parameters during dressing after Coronary Artery Bypass Graft (CABG) surgery. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
CABG, Physiological Parameter, Postoperative Pain
What is being tested?
Virtual Reality Headset and Eye Mask
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
1 siteTurkey (Türkiye)
Study dates
24 Feb 2025to 30 Aug 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adults aged 18-65 years
  • First-time coronary artery bypass graft (CABG) surgery for coronary artery disease
  • ASA physical status I, II, or III
  • Conscious, oriented, and cooperative
  • Able to communicate verbally
  • Provided written informed consent

Who cannot join

  • Presence of sternal wound infection or inflammation
  • Intubated at the time of assessment
  • Undergoing revision surgery
  • Receiving anesthesia or sedation in the ICU
  • Experiencing intraoperative or postoperative complications
  • Inability to speak Turkish
Show all 11Show fewer
  • Hearing or visual impairment
  • Diagnosed psychiatric or cognitive disorder
  • Diagnosis of epilepsy
  • Body mass index (BMI) ≥ 30
  • Participation in another clinical trial during the same period

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Tuğçe Bozkurt Elmas, PhD (c) contact

905063137927

tugce.bozkurt10@ogr.iuc.edu.tr

Turkey (Türkiye)1 site, 1 recruiting
  • Prof. Dr. Cemil Taşçıoğlu City Hospital

    Istanbul, Marmara

    Tuğçe Bozkurt Elmas, PhD(c), 905063137927, tugce.bozkurt10@ogr.iuc.edu.tr

    Ayfer Özbaş, Professor

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Virtual Reality and Eye Mask Application During Dressing After Coronary Artery Bypass Graft Surgery on Sternotomy Pain, Anxiety, and Physiological Parameters

This study aims to evaluate the effects of virtual reality (VR) and eye mask (EM) applications on pain, anxiety, and physiological parameters during dressing after Coronary Artery Bypass Graft (CABG) surgery.

Postoperative dressing procedures, especially after sternotomy, often cause significant pain and anxiety in patients. These issues can negatively impact recovery and increase the need for medication. Non-pharmacological interventions such as VR and EM may help reduce these symptoms.

In this randomized controlled trial, 90 patients are divided into three groups: VR group, EM group, and a control group receiving standard care. Pain and anxiety levels are monitored baseline, immediately after, and 15 minutes after both the first and second dressing procedures. Physiological parameters are measured baseline, during, immediately after, and 15 minutes after both dressing procedures. Additionally, analgesic use is followed baseline and immediately after each dressing procedure. The study is conducted in a cardiovascular intensive care unit in Istanbul, Türkiye. It is expected that the findings will support the integration of VR and EM as effective, low-cost, and non-invasive options for postoperative care, improving patient comfort and healthcare quality.

Read the detailed description

This randomized controlled experimental study investigates the effects of virtual reality (VR) and eye mask (EM) applications on sternotomy pain, anxiety, and physiological parameters during postoperative dressing following Coronary Artery Bypass Graft (CABG) surgery.Pain and anxiety during dressing procedures after CABG surgery can negatively affect the recovery process, increase stress responses, prolong hospital stays, and raise the need for medication. Non-pharmacological interventions such as VR and EM are considered effective strategies for managing these symptoms.

The study includes 90 patients, randomly assigned to one of three groups: VR Group: Patients watched 360-degree nature-themed videos using a virtual reality headset during dressing. EM Group: Patients wore an eye mask during dressing. Control Group: Patients received standard care without any additional intervention. The study is being conducted in the Cardiovascular Surgery Intensive Care Unit of a public hospital located in Istanbul, Türkiye.

Inclusion criteria include adult patients undergoing CABG for the first time, ASA classification I-II-III, fully conscious, oriented, cooperative, and willing to provide informed consent. Exclusion criteria include patients with infections or complications, psychiatric disorders, or sensory impairments such as hearing or vision problems. Pain and anxiety levels are assessed at three time points during both the first and second dressing procedures: baseline, immediately after dressing, and 15 minutes after dressing. Physiological parameters (blood pressure, pulse rate, respiratory rate, oxygen saturation) are measured at four time points: baseline, immediately after dressing, and 15 minutes after dressing. Analgesic use is recorded baseline and immediately after each dressing. This study is one of the first to compare VR and EM interventions in the context of high-risk, postoperative cardiac surgery. The results are expected to contribute to evidence-based nursing practices, improve patient comfort in the postoperative period, and support the use of cost-effective, drug-free alternatives for pain and anxiety management in clinical care.

Being tested
Virtual Reality Headset, Eye Mask
Keywords
Coronary Artery Bypass Graft, Virtual Reality, Eye Mask, Pain Management, Anxiety, Physiological Parameter
Medical subject headings
Pain, Postoperative, Coronary Artery Disease, Agnosia, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual Reality HeadsetDevice

    During the dressing change, nature-themed videos will be shown through a virtual reality headset that immerses the user in a 360-degree, three-dimensional virtual environment.

  • Eye MaskDevice

    A soft, adjustable, 3D-structured eye mask (Poblex brand) will be applied during the dressing procedure.

Study groups in NCT07039812
Study groupRoleWhat they receive
Virtual Reality GroupExperimentalParticipants in this group will watch 360-degree nature-themed videos through a virtual reality headset (Oculus meta quest 2) during both the first and second sternotomy dressing procedures.
Receives: Device: Virtual Reality Headset
Eye Mask GroupExperimentalParticipants in this group will wear an eye mask during both the first and second sternotomy dressing procedures.
Receives: Device: Eye Mask
Control GroupNo interventionParticipants in this group will receive standard postoperative care during dressing, with no additional interventions applied.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analog Scale (VAS)

    Pain intensity will be measured using the Visual Analog Scale (VAS) at three time points: before, immediately after, and 15 minutes after both the first and second sternotomy dressing procedures.

    Measured: Baseline, immediately after, and 15 minutes after first and second dressing

  2. State-Trait Anxiety Inventory (STAI-II)

    State anxiety levels (STAI-I) will be measured before, immediately after, and 15 minutes after both the first and second dressing procedures. Trait anxiety (STAI-II) will be measured only once, before surgery.

    Measured: Baseline, immediately after, and 15 minutes after first and second dressing

Secondary outcomes (4)
  1. Physiological Parameters (Blood pressure)

    Blood pressure will be monitored using a monitor device.

    Measured: Baseline, during, immediately after, and 15 minutes after first and second dressing

  2. Physiological Parameters (Pulse)

    Pulse will be monitored using a monitoring device.

    Measured: Baseline, during, immediately after, and 15 minutes after first and second dressing

  3. Physiological Parameters (SpO₂)

    Saturation values will be monitored using a monitoring device.

    Measured: Baseline, during, immediately after, and 15 minutes after first and second dressing

  4. Physiological Parameters (Respiratory rate )

    Respiratory rate will be monitored using a monitoring device.

    Measured: Baseline, during, immediately after, and 15 minutes after first and second dressing

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jun 2025
  2. Study start24 Feb 2025
  3. Primary completion30 Aug 2025 (estimated)
  4. Study completion30 Aug 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned to one of three parallel arms: VR intervention, eye mask intervention, or standard care control.
Masking
None (open label)
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07039812
Sponsor's protocol ID
CABG-15
Acronym
CABG
Status last verified
Jun 2025
First submitted
3 Jun 2025
Last updated
26 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual Reality Headset and Eye Mask in people with CABG and Physiological Parameter, run by Istanbul University - Cerrahpasa at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Tuğçe Bozkurt Elmas, PhD (c) (905063137927, tugce.bozkurt10@ogr.iuc.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analog Scale (VAS) (time frame: Baseline, immediately after, and 15 minutes after first and second dressing). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in